Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,075 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Low-molecular-weight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hip arthroplasty patients: a double-blind, randomized comparison. The North American Fragmin Trial Investigators.
Hull RD, Pineo GF, Francis C, Bergqvist D, Fellenius C, Soderberg K, Holmqvist A, Mant M, Dear R, Baylis B, Mah A, Brant R. Hull RD, et al. Among authors: francis c. Arch Intern Med. 2000 Jul 24;160(14):2199-207. doi: 10.1001/archinte.160.14.2199. Arch Intern Med. 2000. PMID: 10904464 Clinical Trial.
Prospective analysis of bleeding events in left ventricular assist device patients.
Sherazi S, Kouides P, Francis C, Lowenstein CJ, Refaai M, Conley G, Johnson BA, Muchnik E, Lien S, Massey HT, Alexis JD. Sherazi S, et al. Among authors: francis c. Int J Artif Organs. 2018 May;41(5):269-276. doi: 10.1177/0391398818762353. Epub 2018 Mar 22. Int J Artif Organs. 2018. PMID: 29562808
Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty: a systematic review.
Hull RD, Pineo GF, Stein PD, Mah AF, MacIsaac SM, Dahl OE, Ghali WA, Butcher MS, Brant RF, Bergqvist D, Hamulyák K, Francis CW, Marder VJ, Raskob GE. Hull RD, et al. Among authors: francis cw. Arch Intern Med. 2001 Sep 10;161(16):1952-60. doi: 10.1001/archinte.161.16.1952. Arch Intern Med. 2001. PMID: 11525697 Review.
Low-molecular-weight heparin prophylaxis using dalteparin extended out-of-hospital vs in-hospital warfarin/out-of-hospital placebo in hip arthroplasty patients: a double-blind, randomized comparison. North American Fragmin Trial Investigators.
Hull RD, Pineo GF, Francis C, Bergqvist D, Fellenius C, Soderberg K, Holmqvist A, Mant M, Dear R, Baylis B, Mah A, Brant R. Hull RD, et al. Among authors: francis c. Arch Intern Med. 2000 Jul 24;160(14):2208-15. doi: 10.1001/archinte.160.14.2208. Arch Intern Med. 2000. PMID: 10904465 Clinical Trial.
Comparison of the oral direct thrombin inhibitor ximelagatran with enoxaparin as prophylaxis against venous thromboembolism after total knee replacement: a phase 2 dose-finding study.
Heit JA, Colwell CW, Francis CW, Ginsberg JS, Berkowitz SD, Whipple J, Peters G; AstraZeneca Arthroplasty Study Group. Heit JA, et al. Among authors: francis cw. Arch Intern Med. 2001 Oct 8;161(18):2215-21. doi: 10.1001/archinte.161.18.2215. Arch Intern Med. 2001. PMID: 11575978 Clinical Trial.
1,075 results